Response by Lei et al to Letter Regarding Article, “Modernized Classification of Cardiac Antiarrhythmic Drugs”-Reference-Cited by-同舟云学术

Response by Lei et al to Letter Regarding Article, “Modernized Classification of Cardiac Antiarrhythmic Drugs”

Published:2019-03-26 Issue:13 Volume:139 Page:1652-1653
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Lei Ming¹²,Wu Lin³²,Terrar Derek A.¹,Huang Christopher L.-H.⁴

Affiliation:

1. Department of Pharmacology, University of Oxford, UK (M.L., D.A.T.).

2. Key Laboratory of Medical Electrophysiology of the Ministry of Education and Institute of Cardiovascular Research, Southwest Medical University, Luzhou, China (M.L., L.W.).

3. Department of Cardiology, Peking University First Hospital, China (L.W.).

4. Physiological Laboratory and Department of Biochemistry, University of Cambridge, UK (C.L.-H.H.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Modernized Classification of Cardiac Antiarrhythmic Drugs

2. PAK1 is a novel cardiac protective signaling molecule

3. Multiple targets for flecainide action: implications for cardiac arrhythmogenesis

4. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia

5. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 1,4-Disubstituted Piperazin-2-Ones as Selective Late Sodium Current Inhibitors with QT Interval Shortening Properties in Isolated Rabbit Hearts;Journal of Medicinal Chemistry;2024-05-17